Panoramica bibliografica

  • 2. Cancro al seno



    Alvarado, M. D., Mohan, A. J., Esserman, L. J., Park, C. C., Harrison, B. L., Howe, R. J., Ozanne, E. M. (2013). Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Annals of Surgical Oncology, 20(9), 2873–80.

     

    Alvarado, M. D., Conolly, J., Park, C., Sakata, T., Mohan, A. J., Harrison, B. L., Ozanne, E. M. (2014). Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Research and Treatment, 143(1), 135–140.

     

    Andersen, K. G., Gärtner, R., Kroman, N., Flyger, H., Kehlet, H. (2012). Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomised trial. The Breast, 21(1), 46–49.

     

    Armoogum, K., Parry, J., Mackay, C., Thompson, A., Vaidya, J., Ackland, C., Munro, A. (2007). Measurement of Skin Dose from Very Low Energy X-rays during Partial Breast Irradiation. Clinical Oncology, 19(3), S23.

     

    Benda, R. K., Yasuda, G., Sethi, A., Gabram, S. G. A., Hinerman, R. W., & Mendenhall, N. P. (2003). Breast boost: Are we missing the target? A dosimetric comparison of two boost techniques. Cancer, 97(4), 905–909.
     

    Corica, T., Nowak, A. K., Saunders, C. M., Bulsara, M., Taylor, M., Vaidya, J. S., Joseph, D. J. (2016). Cosmesis and breast-related quality of life outcomes following intra-operative radiotherapy for early breast cancer - a sub-study of the TARGIT-A trial. International Journal of Radiation Oncology*Biology*Physics.
     

    Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Hall, P. (2013). Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. New England Journal of Medicine, 368(11), 987–998

     

    Elsberger, B., Romsauerova, A., Vinnicombe, S., Whelehan, P., Brown, D. C., Dewar, J. A., Evans, A. (2014). Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. European Journal of Surgical Oncology, 40(2), 163–167.

     

    Esposito, E., Anninga, B., Harris, S., Capasso, I., D’Aiuto, M., Rinaldo, M., Douek, M. (2015). Intraoperative radiotherapy in early breast cancer. British Journal of Surgery, 102(6), 599–610.

     

    Esposito, E., Anninga, B., Honey, I., Ross, G., Rainsbury, D., Laws, S., … Douek, M. (2015). Is IORT ready for roll-out? Ecancermedicalscience, 9, 516.

     

    Esserman, L. J., Alvarado, M. D., Howe, R. J., Mohan, A. J., Harrison, B., Park, C., Ozanne, E. M. (2014). Application of a decision analytic framework for adoption of clinical trial results: Are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Research and Treatment, 144(2), 371–378.

     

    Fabris, L., Berton, S., Citron, F., D’Andrea, S., Segatto, I., Nicoloso, M. S., Belletti, B. (2016). Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene, (Novembre 2015), 1–13.

     

    Grobmyer, S. R., Lightsey, J. L., Bryant, C. M., Shaw, C., Yeung, A., Bhandare, N., Copeland, E. M. (2013). Low-kilovoltage, single-dose intraoperative radiation therapy for breast cancer: Results and impact on a multidisciplinary breast cancer program. Journal of the American College of Surgeons, 216(4), 617–624.

     

    Holmes, D. R., Baum, M., Joseph, D. (2007). The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). American Journal of Surgery, 194(4), 507–510.

     

    Holmes, D. R. (2014). Intraoperative radiotherapy in breast conserving surgery. Journal of Surgical Oncology, 110(1), 68–74.

     

    Holmes, D. R. (2015). Intraoperative Radiotherapy of the Breast for Early-Stage Breast Cancer: Ready for Primetime. The Breast Journal, 21(2), 181–184.

     

    Keshtgar, M. R. S., Vaidya, J. S., Tobias, J. S., Wenz, F., Joseph, D., Stacey, C., Baum, M. (2011). Targeted Intraoperative Radiotherapy for Breast Cancer in Patients in Whom External Beam Radiation Is Not Possible. International Journal of Radiation Oncology*Biology*Physics, 80(1), 31–38.

     

    Keshtgar, M. R. S., Williams, N. R., Bulsara, M., Saunders, C., Flyger, H., Cardoso, J. S., Joseph, D. J. (2013). Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Research and Treatment, 140(3), 519–525.

     

    Kolberg, H.-C., Loevey, G., Akpolat-Basci, L., Stephanou, M., Fasching, P. A., Untch, M., Vaidya, J. S. (2017). Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy. Strahlentherapie Und Onkologie, 193(1), 62–69.
     

    Kraus-Tiefenbacher, U., Bauer, L., Kehrer, T., Hermann, B., Melchert, F., Wenz, F. (2006). Intraoperative Radiotherapy (IORT) as a Boost in Patients with Early-Stage Breast Cancer – Acute Toxicity. Oncology Research and Treatment, 29(3), 77–82.

     

    Kraus-Tiefenbacher, U., Bauer, L., Scheda, A., Fleckenstein, K., Keller, A., Herskind, C., Wenz, F. (2006). Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. International Journal of Radiation Oncology*Biology*Physics, 66(2), 377–381.

     

    Kraus-Tiefenbacher, U., Bauer, L., Scheda, A., Schoeber, C., Schaefer, J., Steil, V., Wenz, F. (2007). Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer, 7(1), 178.

     

    Kraus-Tiefenbacher, U., Welzel, G., Brade, J., Hermann, B., Siebenlist, K., Wasser, K. S., Wenz, F. (2010). Postoperative Seroma Formation After Intraoperative Radiotherapy Using Low-Kilovoltage X-Rays Given During Breast-Conserving Surgery. International Journal of Radiation Oncology*Biology*Physics, 77(4), 1140–1145 .


    Lim, S. Z., Yong, W. S., Ho, G. H., Madhukumar, P., Wong, F. Y., Chua, E. T., Ong, K. W. (2014). Early experience with INTRABEAM intra-operative radiotherapy in an Asian population. European Journal of Cancer, 50, S214–S215.

     

    Malter, W., Kirn, V., Richters, L., Fridrich, C., Markiefka, B., Bongartz, R., Kraemer, S. (2014). Intraoperative Boost Radiotherapy during Targeted Oncoplastic Breast Surgery: Overview and Single Center Experiences. International Journal of Breast Cancer, 1–6.

     

    Massa, M., Franchelli, S., Panizza, R., Massa, T. (2016). Is current clinical practice modified about intraoperative breast irradiation? Chinese Journal of Cancer Research, 28(2), 146–149.

     

    Merdad, A. A., Bahadur, Y. A., Fawzy, E. E., Hassouna, A. H., Eltaher, M. M., Alghaithy, Z. K., Constantinescu, C. T. (2013). Phase II study on the use of intraoperative radiotherapy in early breast cancer. Saudi Medical Journal, 34(11), 1133–8.

     

    Mooney, H. (2014). NICE gives go ahead to intrabeam radiotherapy for breast cancer. BMJ, 349(jul28 6), g4863–g4863.

     

    Pan, L., Zheng, W., Ye, X., Chen, L., Ke, Y., Wan, M., … Zhang, X. (2014). A novel approach of INTRABEAM intraoperative radiotherapy for nipple-sparing mastectomy with breast reconstruction. Clinical Breast Cancer, 14(6), 435–441.

     

    Picot, J., Copley, V., Colquitt, J. L., Kalita, N., Hartwell, D., Bryant, J. (2015). The INTRABEAM® photon radiotherapy system for the adjuvant treatment of early breast cancer: A systematic review and economic evaluation. Health Technology Assessment, 19(69), 1–190.

     

    Preuss, J., Lester, L., Saunders, C. (2012). BCCT.core – Can a computer program be used for the assessment of aesthetic outcome after breast reconstructive surgery? The Breast, 21(4), 597–600.

     

    Rivera, R., Banks, A., Casillas-Lopez, A., Rashtian, A., Lewinsky, B., Sheth, P., … Holmes, D. R. (2016). Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast. The Breast Journal, 22(1), 63–74.

     

    Ruano-Ravina, A., Cantero-Muñoz, P., Eraso Urién, A. (2011). Efficacy and safety of intraoperative radiotherapy in breast cancer: A systematic review. Cancer Letters, 313(1), 15–25.

     

    Sedlmayer, F., Reitsamer, R., Wenz, F., Sperk, E., Fussl, C., Kaiser, J., … Fastner, G. (2017). Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiation Oncology, 12(1), 23.

     

    Sedlmayer, F., Zehentmayr, F., Fastner, G. (2013). Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects. The Breast, 22, S141–S146.

     

    Sperk, E., Welzel, G., Keller, A., Kraus-Tiefenbacher, U., Gerhardt, A., Sütterlin, M., Wenz, F. (2012). Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomised phase III trial TARGIT A. Breast Cancer Research and Treatment, 135(1), 253–260.

     

    Sperk, E., Astor, D., Keller, A., Welzel, G., Gerhardt, A., Tuschy, B., Wenz, F. (2014). A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer. Radiation Oncology, 9(1), 154.

     

    Vaidya, J. S., Baum, M., Tobias, J. S., Massarut, S., Wenz, F., Murphy, O., Joseph, D. (2006). Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. International Journal of Radiation Oncology*Biology*Physics, 66(5), 1335–1338.

     

    Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., … Baum, M. (2010). Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. The Lancet, 376(9735), 91–102.

     

    Vaidya, J. S., Baum, M., Tobias, J. S., Wenz, F., Massarut, S., Keshtgar, M., Joseph, D. (2011). Long-Term Results of Targeted Intraoperative Radiotherapy (Targit) Boost During Breast-Conserving Surgery. International Journal of Radiation Oncology*Biology*Physics, 81(4), 1091–1097.

    Vaidya, J. (2013). “1-stop” radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer

     

    Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, M., Baum, M. (2014). Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. The Lancet, 383(9917), 603–613.

     

    Vaidya, J. S., Bulsara, M., Wenz, F., Joseph, D., Saunders, C., Massarut, S., Baum, M. (2015). Pride, prejudice, or science: Attitudes towards the results of the TARGIT-A trial of targeted intraoperative radiation therapy for breast cancer. International Journal of Radiation Oncology Biology Physics, 92(3), 491–497.

     

    Vaidya, J. S., Bulsara, M., Wenz, F., Coombs, N., Singer, J., Ebbs, S., … Baum, M. (2016). Reduced mortality with partial breast irradiation for early breast cancer – a meta-analysis of randomised trials. International Journal of Radiation Oncology*Biology*Physics, 1–7.

     

    Valente, S. A., Tendulkar, R. D., Cherian, S., O’Rourke, C., Greif, J. M., Bailey, L., Grobmyer, S. R. (2016). TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer. Annals of Surgical Oncology.

     

    Wasser, K., Schoeber, C., Kraus-Tiefenbacher, U., Bauer, L., Brade, J., Teubner, J., Neff, W. (2007). Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer. European Radiology, 17(7), 1865–74.

     

    Welzel, G., Blank, E., Kraus-Tiefenbacher, U., Keller, A., Vorodi, F., Herskind, C., Wenz, F. K. (2008). The influence of the interval between IORT during breast-conserving surgery and external beam radiotherapy (EBRT) on late toxicity. Journal of Clinical Oncology, 26, 630.

     

    Welzel, G., Boch, A., Sperk, E., Hofmann, F., Kraus-Tiefenbacher, U., Gerhardt, A., Wenz, F. (2013). Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomised phase III trial TARGIT-A. Radiation Oncology, 8(1), 9.

     

    Wenz, F., Welzel, G., Keller, A., Blank, E., Vorodi, F., Herskind, C., Kraus-Tiefenbacher, U. (2008). Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast, 17(6), 617–622.

     

    Wenz, F., Welzel, G., Blank, E., Hermann, B., Steil, V., Sütterlin, M., Kraus-Tiefenbacher, U. (2010). Intraoperative Radiotherapy as a Boost During Breast-Conserving Surgery Using Low-Kilovoltage X-Rays: The First 5 Years of Experience With a Novel Approach. International Journal of Radiation Oncology*Biology*Physics, 77(5), 1309–1314.

     

    Wenz, F., Blank, E., Welzel, G., Hofmann, F., Astor, D., Neumaier, C., Kraus-Tiefenbacher, U. (2012). Intraoperative radiotherapy during breast-conserving surgery using a miniature x-ray generator (Intrabeam ® ): theoretical and experimental background and clinical experience. Women’s Health, 8(1), 39–47.

     

    Wenz, F., Sedlmayer, F., Herskind, C., Welzel, G., Sperk, E., Neumaier, C., Sütterlin, M. (2015). Accelerated Partial Breast Irradiation in Clinical Practice. Breast Care, 10(4), 247–252.

     

    Williams, N. R., Pigott, K. H., Brew-Graves, C., Keshtgar, M. R. S. (2014). Intraoperative radiotherapy for breast cancer. Gland Surgery, 3(2), 109–119.

  • 10. IORT generica

     

     

    Biggs, D. S., Thomson, E. S. (1996). Radiation properties of a miniature X-ray device for radiosurgery. The British Journal of Radiology, 69(822), 544–7.

     

    Calvo, F. A. (2017). Intraoperative irradiation: precision medicine for quality cancer control promotion. Radiation Oncology, 12(1), 36.

    Calvo, F. A., Sole, C. V, González, M. E., Tangco, E. D., López-Tarjuelo, J., Koubychine, I., … Ferrer, C. (2013). Research opportunities in intraoperative radiation therapy: the next decade 2013–2023. Clinical and Translational Oncology, 15(9), 683–690.

     

    Coles, C. E., Yarnold, J. R. (2016). Accelerated partial breast irradiation: the new standard? The Lancet, 387(10015), 201–202.

     

    Debenham, B. J., Hu, K. S., Harrison, L. B. (2013). Present status and future directions of intraoperative radiotherapy. The Lancet Oncology, 14(11), e457–e464.

     

    Eaton, D. J. (2015). Electronic brachytherapy—current status and future directions. The British Journal of Radiology, 88(1049), 20150002.

     

    Holmes, D. R. (2015). Intraoperative Radiotherapy of the Breast for Early-Stage Breast Cancer: Ready for Primetime. The Breast Journal, 21(2), 181–184.

     

    Mooney, H. (2014). NICE gives go ahead to intrabeam radiotherapy for breast cancer. BMJ, 349(jul28 6), g4863–g4863.

     

    Kalakota, K., Small, W. (2014). Intraoperative radiation therapy techniques and options for breast cancer. Expert Review of Medical Devices, 11(3), 265–73.

     

    Paolo, V., De Lorenzi Francesca, Pietro, L., Mario, R., Umberto, V. (2016). Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment. Aesthetic Plastic Surgery, 40(2), 256–265.

     

    Thariat, J., Hannoun-Levi, J.-M., Sun Myint, A., Vuong, T., Gérard, J.-P. (2012). Past, present, and future of radiotherapy for the benefit of patients. Nature Reviews Clinical Oncology, 10(1), 52–60.

     

    Tobias, J. S., Vaidya, J. S., Keshtgar, M., D’Souza, D. P., Baum, M. (2004). Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. The British Journal of Radiology, 77(916), 279–84.

  • 11. Linee guida

     

     

    AGO. (2014). Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer, Guidelines(Ver. 1).

     

    Aetna. (2015). Intraoperative Radiation Therapy (IORT).

    DEGRO. (n.d.). Leitlinie zur Weiterbildung zum Facharzt für Strahlentherapie.

    Gnant, M., Harbeck, N., Thomssen, C. (2011). St. Gallen 2011: Summary of the consensus discussion. Breast Care, 6(2), 136–141.

     

    Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., Senn, H. J. (2011). Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Annals of Oncology, 22(8), 1736–1747.

     

    NCCN. (2015). NCCN Clinical Practice Guidelines in Oncology - Breast Cancer.

    NCCN. (2016). NCCN Clinical Practice Guidelines in Oncology - Colon Cancer.


    NCCN. (2016). NCCN Clinical Practice Guidelines in Oncology - Rectal Cancer.

     

    Polgár, C., Limbergen, E. Van, Pötter, R., Kovács, G., Polo, A., Lyczek, J., Strnad, V. (2010). Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group. Radiotherapy and Oncology, 94(3), 264–273.

     

    Sedlmayer, F., Sautter-Bihl, M. L., Budach, W., Dunst, J., Fastner, G., Feyer, P., Sauer, R. (2013). DEGRO practical guidelines: Radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer. Strahlentherapie Und Onkologie, 189(10), 825–833.

     

    Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Harris, J. R. (2009). Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO). International Journal of Radiation Oncology*Biology*Physics, 74(4), 987–1001.

     

Raccolta dei media

prodotti

Loading the player...

IORT di ZEISS

Imparate di più sul cancro e sui vantaggi che la radioterapia intraoperatoria (IORT) offre per il trattamento di questa patologia. Scoprite l'ampia gamma di indicazioni oncologiche già supportate da ZEISS e come il vostro ambiente radioterapico possa trarre vantaggio dalla IORT di ZEISS.

Loading the player...

INTRABEAM 600 di ZEISS - La terza generazione

INTRABEAM 600 di ZEISS è la prima piattaforma di trattamento per IORT completamente integrata e collegata a DICOM che soddisfa molteplici esigenze cliniche in un'unica soluzione.

Loading the player...

Funzionamento della sorgente di raggi X (XRS) di INTRABEAM® di ZEISS

Questo video descrive i componenti e le funzionalità della XRS. Guardate cosa accade all'interno della XRS durante il trattamento IORT.

Indicazioni

Loading the player...

Come funziona la IORT per il cancro al seno

Questo video mostra un intervento di chirurgia conservativa del seno (BCS) con IORT e descrive le varie fasi del trattamento.

Loading the player...

Come funziona la Cifo-IORT per metastasi spinali

Questo video mostra le differenti fasi della tecnica Cifo-IORT utilizzata per trattare un paziente con metastasi spinali..

Loading the player...

Come funziona la IORT con vertebroplastica per metastasi spinali

Questo video mostra le differenti fasi della vertebroplastica combinata con la tecnica IORT per trattare un paziente con metastasi spinali.